Usually, generic drugs are as effective as their master drugs and become available to patients at a very low cost. Due to their low price nature, generic drugs are being used across the world and the governments are devising strategies to make them more accessible to society.
 
 Japan is one of the leading pharmaceutical markets in the world; however, the share of generics has been low. Public perception is the key factor for such a low share. However, the government has played a vital role in promoting generic drugs across the country by spreading awareness regarding benefits and quality. Good promotional activities have largely benefitted Japanese generics market during the past few years and with total size of around US$ 8 Billion in 2010, the market is poised to grow at a fast pace. The patent expiry of branded drugs and active ingredients will act as growth drivers for the market in future and the government support will strengthen market potential.
 
 Currently, the Japanese generics market is characterized by the presence of major global pharmaceutical players. These players have been devising strategies and making alliances with domestic manufacturers to enlarge their market share. Companies, such as Pfizer, Merck, Sandoz etc. are likely to play a prominent role in expanding generic drugs market in Japan in near future. The role of NHI pharmacies and DPC hospitals is also being valued as exceptional in the positive industry developments. Focus on strong marketing and cardiovascular generics are the trends positively affecting market in an effective manner.
 
 The report “Japanese Generic Market Forecast to 2013” provides an in-depth research and prudent analysis on the generic market in Japan. It analyzes the current trends prevailing in the generic market and investigates their impact on the future shape of the industry. The report also covers the performance of key players in the Japanese generic markets. Moreover, based on various present and future indicators, the future scenario of the market has been analyzed and presented in the report.
 
 Table of Contents:
 
 1. Analyst View
 2. The Japanese Pharmaceutical Market: Overview
 3. Recent Market Trends
 3.1 Important Role of NHI Pharmacies and DPC Hospitals
 3.2 Expansion of Foreign Generic Drugs Manufacturers
 3.3 Quality Driven Approach in Market
 3.4 Cardiovascular Generic Drugs
 3.5 Renowned Focus on Marketing
 4. The Japanese Generic Drugs Market
 4.1 Industry Overview
 4.2 Market Segmentation
 4.3 Distribution Channels
 4.4 Key Manufacturers
 4.5 Therapeutic Segment
 5. Consumer Behavior Analysis
 6. Regulatory Environment
 7. Opportunity Assessme
 
 For more information kindly visit :
 http://www.bharatbook.com/detail.asp?id=85878&rt=Japanese-Generic-Market-Forecast-to-2013.html
 
 Related Reports
 Anticonvulsants Market to 2016 - Cost Advantage and Dosage Convenience Provided by Generic Anticonvulsants Will Limit Commercial Opportunities for Novel Therapies
 http://www.bharatbook.com/detail.asp?id=172145&rt=Anticonvulsants-Market-to-2016-Cost-Advantage-and-Dosage-Convenience-Provided-by-Generic-Anticonvulsants-Will-Limit-Commercial-Opportunities-for-Novel-Therapies.html
 
 Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars
 http://www.bharatbook.com/detail.asp?id=185840&rt=Cancer-Supportive-Care-Products-Market-to-2016-Market-is-Expected-to-Decline-after-2014-Due-to-Generic-Erosion-and-Entry-of-Biosimilars.html
 
 -30-
 
 Or
 
 Contact us at :
 
 Bharat Book Bureau
 Tel: +91 22 27578668
 Fax: +91 22 27579131
 Email: info@bharatbook.com
 Website: www.bharatbook.com
 Follow us on twitter: http://twitter.com/#!/BharatBook
 Please visit our blog at http://bharatresearch.wordpress.com